Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,073 recruiting studies in this area right now.
By phase
- Not applicable4,179
- Phase 2597
- Phase 1410
- Phase 3326
- Phase 4250
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer336
- Cervical Cancer223
- Endometrial Cancer206
- Bladder Cancer186
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence60
Leading sponsors
- Mayo Clinic60
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca37
- University of Colorado, Denver37
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California348
- Alabama153
- Texas119
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,073 total
- NCT07619820RecruitingPhase 1
CSL300 Safety Study for Kidney Dialysis Patients
This study tests how a new drug called CSL300 (clazakizumab) works in the body of people with end-stage kidney disease who are on dialysis. Researchers want to understand if it's safe and how your body processes it.
BeijingAges 18 years+ - NCT07620574Enrolling by invitationPhase 3
Long-Term Study Continuing Cancer Treatment from Previous Trial
This study lets people who were in an earlier Exelixis cancer treatment trial continue receiving the same treatment if it's still helping them. It's designed to see how safe and effective the treatment is over a longer period.
Bay Shore, New YorkAges Any age - NCT07614477RecruitingPhase 2
Testing EVER001 for kidney protein-loss diseases
This study tests a new drug called EVER001 to see if it can reduce protein loss in urine and improve kidney function in patients with specific kidney diseases (FSGS, MCD, or IgAN). These are autoimmune kidney conditions that cause the kidneys to leak protein into the urine.
Beijing, Beijing MunicipalityAges 18–75 - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT07617753RecruitingPhase 1/Phase 2
CAR-NK Cell Therapy for Recurrent Ovarian Cancer
This trial tests a new type of cell therapy using modified natural killer cells (CAR-NK cells) that are trained to attack ovarian cancer cells. It's designed for patients whose cancer has come back or stopped responding to previous treatments.
Shenzhen, GuangdongAges 18–75 - NCT06708234Recruiting
Comparing two ways to close the uterus after C-section
This study compares two ways of closing the uterus after a C-section (single-layer vs double-layer) to see which one leads to fewer small pockets in the scar. If you've had or are planning a C-section, you may be able to help understand which method is better for healing.
Udine, UdineAges 18 years+ - NCT06705283Recruiting
Yoga and vibration for stress incontinence in women
This trial tests whether yoga and vibration training can help women with stress urinary incontinence. It compares a group doing pelvic floor exercises with a group doing yoga and vibration training to see which works better.
IspartaAges 20–60 - NCT06706115Recruiting
Testing breast milk nasal drops in preterm babies
This study tests whether putting a few drops of breast milk into a preterm baby's nose can help their brain get more oxygen. It is for babies who are not yet ready to feed all by mouth and who don't have certain health problems.
KonyaAges 6 months–9 months - NCT05969431Recruiting
Measuring hair cortisol to study stress in fathers of babies
This study looks at whether a father’s stress level over time can be estimated by measuring cortisol (a stress hormone) in hair. Results may help researchers better understand how chronic stress affects new families, especially when babies are born early or on time.
Cologne, Northrhine-westfaliaAges 1 day–1 week - NCT06021288Recruiting
Standard vs. lower dose dialysis for kidney failure in intensive care
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
MünsterAges 18 years+ - NCT06437353RecruitingPhase 2
Surufatinib combo for first-line and maintenance in high-risk ovarian cancer
This trial tests a combination of drugs (Surufatinib with carboplatin/paclitaxel) as first treatment for high-risk ovarian cancer, followed by a different combination (Surufatinib with olaparib) to keep the cancer from coming back. It aims to see if these targeted therapies work better than the standard approach.
Hefei, AnhuiAges 18–75 - NCT06674031Recruiting
Survey on heart risk knowledge in kidney disease
This study aims to understand how much people with chronic kidney disease know about heart disease risk factors. It involves a simple questionnaire (no drugs or procedures) to help improve patient education.
AnkaraAges 18–65 - NCT06707532Recruiting
Muscle relaxants for safer heart rhythm treatment
This study tests if giving muscle relaxants before a heart ablation procedure can protect muscles from damage. Ablation uses energy to fix irregular heartbeats, and muscle relaxants might make it safer.
Wroclaw, Lower Silesian VoivodeshipAges 18–90 - NCT06706921RecruitingPhase 4
Predicting treatment success with PET scans in prostate cancer
This study looks at whether a special PET scan can help predict how well a targeted radiation therapy (LuPSMA) works in men with advanced prostate cancer that has spread. You would get several PET scans before and after treatment to see if the scan results can forecast your outcome.
Los Angeles, CaliforniaAges 18 years+ - NCT05612022Recruiting
Sound recording during hemodialysis fistula decisions
This study records and analyzes sounds from people getting hemodialysis through an access in the arm (an AV fistula or graft). It aims to see whether sound patterns can help assess or guide the best vascular access approach for dialysis.
Bergamo, BGAges 18–90 - NCT06709690Recruiting
AI-powered PET/MR scanner for children with suspected cancer
This study tests a new, fast, and quiet AI-powered PET/MR scanner to take detailed pictures of children with suspected cancer. It aims to make the imaging experience easier and more comfortable for kids.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT07611448Enrolling by invitation
AI Tool to Help Select the Best Embryo for Pregnancy
This study tests whether artificial intelligence can better identify which embryos are most likely to result in a successful pregnancy during fertility treatment. Researchers will use an AI system to analyze embryo images on days 5–7 of development to help doctors choose the best embryo to transfer.
Clovis, CaliforniaAges 18–45 - NCT07603895Recruiting
Probiotic treatment for yeast infections
This study tests whether a probiotic product (good bacteria) can help treat vulvovaginal yeast infections alongside standard care. You'll use the probiotic for a set period and report how your symptoms improve.
Torrevieja, AlicanteAges Any age - NCT07607470Recruiting
Vaginal Health Symptom Study with New Testing Method
This study tests a new way to diagnose vaginal infections by collecting samples from the vagina. If you have symptoms like unusual discharge, itching, burning, or odor, this research may help improve how doctors identify what's causing your discomfort.
North Miami, FloridaAges 18 years+ - NCT07604766RecruitingPhase 3
Rina-S for platinum-resistant ovarian cancer in China
This study tests a new cancer drug called Rina-S (an antibody-drug conjugate, which is a targeted therapy that delivers medicine directly to cancer cells) compared to standard treatment options for ovarian cancer that has returned or worsened after platinum chemotherapy. The trial is specifically for patients in China whose cancer is resistant to platinum drugs.
ChangchunAges 18 years+ - NCT07610798RecruitingPhase 1/Phase 2
Testing INV-8989 for Advanced Cancers With KRAS G12D Mutation
This early-stage trial tests a new drug called INV-8989 designed to target a specific genetic mutation (KRAS G12D) found in some advanced solid cancers. The study will evaluate whether the drug is safe and if it can help shrink tumors in patients who haven't responded to standard treatments.
Guangzhou, GuangdongAges 18 years+ - NCT07611214RecruitingPhase 4
LUPKYNIS Combined With Immune-Targeting Drugs for Lupus Kidney Disease
This study tests whether adding LUPKYNIS (a drug that protects the kidney) to one of three immune-system medications helps people with lupus nephritis (lupus affecting the kidneys). The goal is to reduce protein in urine and protect kidney function.
La Mesa, CaliforniaAges 18–75 - NCT05654649RecruitingPhase 1/Phase 2
Dexamethasone to prevent bowel blockage after C-section
This trial studies whether a medicine called dexamethasone can help prevent bowel “slow-down” (ileus) after a C-section done with spinal anesthesia. If you qualify, you may receive the study medicine to see if it helps you recover your bowel function faster.
AsyutAges 18–40 - NCT02563600Recruiting
Text support to help women attend pelvic floor physiotherapy
This study tests whether brief text-message support can improve how often people attend pelvic floor physiotherapy appointments. It may help by offering reminders or encouragement while you are waiting for care.
SwanseaAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,073 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,800 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.